Trial intelligence / Profile preview

Cervical Cerclage and Progesterone in Twin Pregnancy with Short Cervix

NCT03077633Phase 3Withdrawn

Sponsor
Pediatrix Medical Group
Start
Oct 2017
Primary completion
Jan 2018
01

Overview

Phase 3, randomised, open-label trial (2 arms), sponsored by Pediatrix Medical Group. Primary endpoints: Preterm birth before 32 weeks and Adverse perinatal outcome. Planned start Oct 2017; status: withdrawn.

Beyond the preview

Go deeper on NCT03077633.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03077633.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call